The European Commission has published an updated version of its Questions and Answers on general methodological and procedural issues for joint clinical assessments. The Q&A includes responses to questions concerning:
steps to be taken when available data does not permit an exact analysis of PICO (Population, Intervention, Comparator, Outcome) elements;
the appropriate approach where the population included in a trial is wider than the population required in a PICO;
the approach to adopt where no direct comparison is available for a specific PICO; and
the consequences where a developer does not agree with a PICO included in the assessment scope.